000 | 01101 a2200361 4500 | ||
---|---|---|---|
005 | 20250512230803.0 | ||
264 | 0 | _c19840629 | |
008 | 198406s 0 0 eng d | ||
022 | _a0361-5960 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSessa, C | |
245 | 0 | 0 |
_aTeniposide in refractory ovarian cancer: a phase II study. _h[electronic resource] |
260 |
_bCancer treatment reports _cMay 1984 |
||
300 |
_a815-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Parenteral |
650 | 0 | 4 |
_aLeukopenia _xchemically induced |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNausea _xchemically induced |
650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPodophyllotoxin _xanalogs & derivatives |
650 | 0 | 4 |
_aTeniposide _xtherapeutic use |
700 | 1 | _aD'Incalci, M | |
700 | 1 | _aLandoni, F | |
700 | 1 | _aColombo, N | |
700 | 1 | _aMangioni, C | |
773 | 0 |
_tCancer treatment reports _gvol. 68 _gno. 5 _gp. 815-6 |
|
999 |
_c6722624 _d6722624 |